 Monika Headrick
Concepts (536)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 42 | 2023 | 1183 | 4.600 |
Why?
| | Erythrocytes | 28 | 2024 | 750 | 4.220 |
Why?
| | Blood Proteins | 11 | 2020 | 230 | 3.510 |
Why?
| | Proteome | 20 | 2022 | 515 | 3.140 |
Why?
| | Blood Preservation | 16 | 2024 | 345 | 3.050 |
Why?
| | Erythrocyte Transfusion | 9 | 2023 | 226 | 2.510 |
Why?
| | Hemolysis | 12 | 2024 | 242 | 2.200 |
Why?
| | Fibrinolysis | 7 | 2022 | 164 | 1.860 |
Why?
| | Extracellular Matrix Proteins | 5 | 2021 | 156 | 1.650 |
Why?
| | Extracellular Matrix | 8 | 2023 | 560 | 1.480 |
Why?
| | Mass Spectrometry | 14 | 2019 | 743 | 1.380 |
Why?
| | Chromatography, Liquid | 7 | 2017 | 444 | 1.240 |
Why?
| | Blood Coagulation Disorders | 5 | 2023 | 196 | 1.220 |
Why?
| | Mesentery | 3 | 2014 | 44 | 1.190 |
Why?
| | Anemia, Sickle Cell | 4 | 2023 | 312 | 1.090 |
Why?
| | Wounds and Injuries | 6 | 2022 | 960 | 1.050 |
Why?
| | beta-Thalassemia | 4 | 2023 | 40 | 1.040 |
Why?
| | Tissue Plasminogen Activator | 6 | 2023 | 244 | 0.990 |
Why?
| | Lymph | 3 | 2018 | 31 | 0.990 |
Why?
| | Tandem Mass Spectrometry | 7 | 2016 | 565 | 0.970 |
Why?
| | Plasma | 4 | 2017 | 223 | 0.950 |
Why?
| | Blood Coagulation | 6 | 2023 | 268 | 0.900 |
Why?
| | Tissue Scaffolds | 2 | 2019 | 223 | 0.870 |
Why?
| | Plateletpheresis | 2 | 2015 | 28 | 0.860 |
Why?
| | Survival of Motor Neuron 1 Protein | 2 | 2016 | 13 | 0.850 |
Why?
| | Blood Platelets | 4 | 2015 | 379 | 0.840 |
Why?
| | Reticulocytes | 1 | 2023 | 17 | 0.810 |
Why?
| | Lipopolysaccharides | 10 | 2022 | 854 | 0.810 |
Why?
| | Extracellular Vesicles | 5 | 2023 | 171 | 0.780 |
Why?
| | Isoantibodies | 1 | 2023 | 57 | 0.780 |
Why?
| | Blood Donors | 5 | 2024 | 143 | 0.730 |
Why?
| | Arginine | 1 | 2022 | 238 | 0.680 |
Why?
| | Oxidative Stress | 10 | 2022 | 1338 | 0.670 |
Why?
| | Metabolome | 4 | 2021 | 385 | 0.670 |
Why?
| | Shock, Hemorrhagic | 5 | 2023 | 202 | 0.620 |
Why?
| | Humans | 81 | 2024 | 144667 | 0.620 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 4 | 2017 | 324 | 0.610 |
Why?
| | Acellular Dermis | 1 | 2019 | 11 | 0.610 |
Why?
| | Animals | 38 | 2023 | 37948 | 0.600 |
Why?
| | Sex Characteristics | 3 | 2015 | 776 | 0.590 |
Why?
| | Lipid Metabolism | 2 | 2017 | 524 | 0.580 |
Why?
| | Thrombelastography | 7 | 2023 | 190 | 0.560 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 387 | 0.560 |
Why?
| | Coronavirus Infections | 2 | 2020 | 381 | 0.550 |
Why?
| | Hypoxia | 7 | 2023 | 1193 | 0.550 |
Why?
| | Metabolomics | 7 | 2024 | 724 | 0.550 |
Why?
| | Complement System Proteins | 2 | 2021 | 314 | 0.540 |
Why?
| | Hemoglobins | 4 | 2022 | 381 | 0.540 |
Why?
| | Tissue Engineering | 3 | 2019 | 441 | 0.530 |
Why?
| | Hydroxylamine | 1 | 2017 | 7 | 0.530 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2017 | 85 | 0.520 |
Why?
| | Hydrogels | 4 | 2023 | 703 | 0.510 |
Why?
| | Mice | 19 | 2023 | 18261 | 0.490 |
Why?
| | Interleukin-6 | 2 | 2020 | 770 | 0.490 |
Why?
| | Mycophenolic Acid | 1 | 2017 | 120 | 0.480 |
Why?
| | Nucleotides | 1 | 2017 | 130 | 0.480 |
Why?
| | Campylobacter jejuni | 3 | 2011 | 16 | 0.470 |
Why?
| | Coiled Bodies | 1 | 2016 | 9 | 0.470 |
Why?
| | Pandemics | 3 | 2023 | 1700 | 0.460 |
Why?
| | Microtubule-Associated Proteins | 2 | 2021 | 195 | 0.460 |
Why?
| | Hydroxylysine | 1 | 2015 | 4 | 0.450 |
Why?
| | Myocardium | 3 | 2022 | 928 | 0.450 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 2 | 2020 | 34 | 0.440 |
Why?
| | Extinction, Biological | 1 | 2015 | 38 | 0.430 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2016 | 191 | 0.420 |
Why?
| | Oxidation-Reduction | 7 | 2021 | 1078 | 0.410 |
Why?
| | Neutrophils | 4 | 2022 | 1118 | 0.400 |
Why?
| | Lymph Nodes | 2 | 2018 | 501 | 0.380 |
Why?
| | Proteolysis | 2 | 2017 | 170 | 0.380 |
Why?
| | Paxillin | 1 | 2022 | 11 | 0.380 |
Why?
| | Erythrocyte Deformability | 1 | 2022 | 23 | 0.380 |
Why?
| | Thrombophilia | 1 | 2023 | 89 | 0.370 |
Why?
| | Collagen | 1 | 2015 | 450 | 0.370 |
Why?
| | Repressor Proteins | 1 | 2016 | 428 | 0.370 |
Why?
| | Valosin Containing Protein | 1 | 2022 | 8 | 0.370 |
Why?
| | Superoxides | 2 | 2022 | 199 | 0.360 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2012 | 68 | 0.360 |
Why?
| | Immunosuppressive Agents | 1 | 2017 | 834 | 0.360 |
Why?
| | O Antigens | 3 | 2006 | 8 | 0.360 |
Why?
| | Cytoplasmic Dyneins | 1 | 2021 | 8 | 0.360 |
Why?
| | Cell Proliferation | 6 | 2022 | 2489 | 0.350 |
Why?
| | Autoimmune Diseases of the Nervous System | 1 | 2022 | 31 | 0.350 |
Why?
| | Oxygen | 3 | 2022 | 984 | 0.350 |
Why?
| | Nervous System Malformations | 1 | 2022 | 46 | 0.340 |
Why?
| | Nanoparticles | 2 | 2022 | 512 | 0.340 |
Why?
| | Carnitine | 1 | 2022 | 90 | 0.340 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 6 | 2021 | 835 | 0.340 |
Why?
| | Glycolysis | 4 | 2022 | 341 | 0.340 |
Why?
| | Plesiomonas | 3 | 2006 | 3 | 0.340 |
Why?
| | Intestinal Mucosa | 1 | 2017 | 675 | 0.330 |
Why?
| | Biomarkers | 8 | 2022 | 4261 | 0.330 |
Why?
| | Gangliosides | 1 | 2011 | 23 | 0.330 |
Why?
| | Male | 28 | 2023 | 72431 | 0.320 |
Why?
| | Endosomes | 1 | 2021 | 140 | 0.320 |
Why?
| | B7-H1 Antigen | 1 | 2022 | 242 | 0.320 |
Why?
| | Female | 27 | 2023 | 78304 | 0.300 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2019 | 49 | 0.300 |
Why?
| | Molecular Sequence Data | 9 | 2015 | 2909 | 0.290 |
Why?
| | Proteins | 2 | 2023 | 1016 | 0.290 |
Why?
| | Glioblastoma | 1 | 2022 | 353 | 0.290 |
Why?
| | Prostatic Neoplasms, Castration-Resistant | 1 | 2019 | 53 | 0.290 |
Why?
| | Resuscitation | 3 | 2017 | 310 | 0.290 |
Why?
| | Androgen Antagonists | 1 | 2019 | 92 | 0.280 |
Why?
| | Breast Neoplasms | 3 | 2022 | 2365 | 0.280 |
Why?
| | Biological Products | 1 | 2022 | 256 | 0.280 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 426 | 0.280 |
Why?
| | Thrombosis | 1 | 2022 | 396 | 0.280 |
Why?
| | Cellular Reprogramming | 2 | 2021 | 99 | 0.280 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2022 | 1207 | 0.280 |
Why?
| | Protein Processing, Post-Translational | 3 | 2019 | 466 | 0.280 |
Why?
| | Cells, Cultured | 7 | 2021 | 4110 | 0.280 |
Why?
| | Androgens | 1 | 2019 | 178 | 0.270 |
Why?
| | Hematopoietic Stem Cells | 1 | 2021 | 419 | 0.260 |
Why?
| | Lymphokines | 1 | 2017 | 128 | 0.260 |
Why?
| | Energy Metabolism | 3 | 2022 | 927 | 0.260 |
Why?
| | Leukocyte Reduction Procedures | 2 | 2018 | 29 | 0.260 |
Why?
| | Asparagine | 2 | 2018 | 34 | 0.250 |
Why?
| | Brain Injuries, Traumatic | 1 | 2023 | 451 | 0.250 |
Why?
| | Ketones | 1 | 2017 | 53 | 0.250 |
Why?
| | alpha 1-Antitrypsin | 2 | 2022 | 102 | 0.250 |
Why?
| | Adult | 18 | 2023 | 40489 | 0.250 |
Why?
| | Chondrogenesis | 2 | 2020 | 88 | 0.250 |
Why?
| | Apocrine Glands | 1 | 2016 | 4 | 0.250 |
Why?
| | Aldehydes | 1 | 2017 | 141 | 0.250 |
Why?
| | Xanthine Dehydrogenase | 1 | 2016 | 24 | 0.240 |
Why?
| | Neutrophil Activation | 2 | 2018 | 84 | 0.240 |
Why?
| | Inflammation | 7 | 2023 | 2870 | 0.240 |
Why?
| | Rats | 7 | 2023 | 5570 | 0.240 |
Why?
| | Transcriptome | 3 | 2022 | 1036 | 0.240 |
Why?
| | Cell Line, Tumor | 7 | 2022 | 3523 | 0.230 |
Why?
| | Glycolipids | 1 | 2016 | 52 | 0.230 |
Why?
| | Molecular Chaperones | 1 | 2017 | 181 | 0.230 |
Why?
| | Middle Aged | 14 | 2023 | 35971 | 0.230 |
Why?
| | Milk | 1 | 2016 | 119 | 0.230 |
Why?
| | Time Factors | 6 | 2018 | 7140 | 0.230 |
Why?
| | Injury Severity Score | 2 | 2018 | 602 | 0.230 |
Why?
| | Hemorrhage | 4 | 2023 | 813 | 0.230 |
Why?
| | Lung | 3 | 2015 | 4089 | 0.230 |
Why?
| | Multiple Organ Failure | 2 | 2022 | 119 | 0.220 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2022 | 657 | 0.220 |
Why?
| | Electrophoresis, Capillary | 3 | 2008 | 19 | 0.220 |
Why?
| | Magnetic Resonance Spectroscopy | 4 | 2017 | 625 | 0.220 |
Why?
| | Glycoproteins | 1 | 2016 | 353 | 0.210 |
Why?
| | Protein Conformation | 1 | 2017 | 935 | 0.210 |
Why?
| | Cell Membrane | 2 | 2016 | 706 | 0.210 |
Why?
| | Amino Acid Sequence | 4 | 2015 | 2136 | 0.210 |
Why?
| | Chromosomal Proteins, Non-Histone | 2 | 2015 | 129 | 0.210 |
Why?
| | Ubiquitination | 2 | 2016 | 117 | 0.200 |
Why?
| | Blood Group Antigens | 1 | 2023 | 15 | 0.200 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2023 | 14 | 0.200 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2019 | 881 | 0.200 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2022 | 268 | 0.200 |
Why?
| | Interferons | 2 | 2022 | 185 | 0.200 |
Why?
| | Epitopes | 3 | 2008 | 479 | 0.200 |
Why?
| | Bacteria | 2 | 2022 | 894 | 0.200 |
Why?
| | Birth Injuries | 1 | 2023 | 18 | 0.200 |
Why?
| | Reactive Oxygen Species | 5 | 2022 | 601 | 0.190 |
Why?
| | Swine | 3 | 2023 | 828 | 0.190 |
Why?
| | Hypocalcemia | 1 | 2023 | 38 | 0.190 |
Why?
| | Glucose | 3 | 2018 | 1033 | 0.190 |
Why?
| | Haemophilus influenzae | 2 | 2008 | 67 | 0.190 |
Why?
| | Acute-Phase Proteins | 2 | 2014 | 66 | 0.190 |
Why?
| | Brain Neoplasms | 1 | 2022 | 1327 | 0.190 |
Why?
| | Solubility | 2 | 2017 | 236 | 0.190 |
Why?
| | Sphingosine | 1 | 2023 | 45 | 0.190 |
Why?
| | DNA Modification Methylases | 1 | 2022 | 18 | 0.190 |
Why?
| | Proteasome Endopeptidase Complex | 3 | 2022 | 153 | 0.190 |
Why?
| | Carbohydrate Sequence | 7 | 2008 | 29 | 0.190 |
Why?
| | Serpins | 1 | 2022 | 28 | 0.190 |
Why?
| | Arginase | 1 | 2022 | 25 | 0.190 |
Why?
| | Lysophospholipids | 1 | 2023 | 78 | 0.190 |
Why?
| | Pelvic Organ Prolapse | 1 | 2023 | 62 | 0.180 |
Why?
| | Platelet Transfusion | 1 | 2023 | 78 | 0.180 |
Why?
| | Rejuvenation | 2 | 2021 | 18 | 0.180 |
Why?
| | Protein Transport | 2 | 2021 | 437 | 0.180 |
Why?
| | Citrulline | 1 | 2022 | 46 | 0.180 |
Why?
| | Erythroblasts | 1 | 2022 | 18 | 0.180 |
Why?
| | Blood Banks | 2 | 2021 | 50 | 0.180 |
Why?
| | beta-Globins | 1 | 2022 | 8 | 0.180 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2022 | 70 | 0.180 |
Why?
| | Fibrinolysin | 1 | 2022 | 19 | 0.180 |
Why?
| | Isoaspartic Acid | 1 | 2021 | 3 | 0.180 |
Why?
| | Protein D-Aspartate-L-Isoaspartate Methyltransferase | 1 | 2021 | 5 | 0.180 |
Why?
| | Anion Exchange Protein 1, Erythrocyte | 1 | 2021 | 23 | 0.180 |
Why?
| | Signal Transduction | 6 | 2022 | 5185 | 0.170 |
Why?
| | Blood | 1 | 2022 | 106 | 0.170 |
Why?
| | Case-Control Studies | 5 | 2022 | 3603 | 0.170 |
Why?
| | Methods | 2 | 2018 | 68 | 0.170 |
Why?
| | Macrophages | 4 | 2023 | 1496 | 0.170 |
Why?
| | Receptors, Glucocorticoid | 1 | 2022 | 130 | 0.170 |
Why?
| | Cell Cycle Proteins | 3 | 2022 | 628 | 0.170 |
Why?
| | Erythrocyte Membrane | 1 | 2021 | 54 | 0.170 |
Why?
| | Endothelial Cells | 3 | 2023 | 864 | 0.170 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2015 | 418 | 0.160 |
Why?
| | Seroconversion | 1 | 2021 | 48 | 0.160 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2020 | 35 | 0.160 |
Why?
| | Virulence Factors | 1 | 2022 | 177 | 0.160 |
Why?
| | Betacoronavirus | 2 | 2020 | 286 | 0.160 |
Why?
| | Hypertension, Pulmonary | 2 | 2022 | 1948 | 0.160 |
Why?
| | Thrombin | 3 | 2023 | 167 | 0.160 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2022 | 294 | 0.160 |
Why?
| | Membrane Lipids | 1 | 2020 | 82 | 0.160 |
Why?
| | Saccharomyces cerevisiae | 2 | 2015 | 579 | 0.160 |
Why?
| | Databases, Genetic | 1 | 2021 | 247 | 0.160 |
Why?
| | Lipid A | 2 | 2008 | 27 | 0.160 |
Why?
| | Cell Line | 5 | 2018 | 2821 | 0.150 |
Why?
| | Antibodies, Bacterial | 2 | 2008 | 146 | 0.150 |
Why?
| | Protein Stability | 2 | 2017 | 177 | 0.150 |
Why?
| | Spermatogenesis | 1 | 2020 | 91 | 0.150 |
Why?
| | Aging | 3 | 2021 | 1938 | 0.150 |
Why?
| | Parabiosis | 1 | 2019 | 11 | 0.150 |
Why?
| | Nitric Oxide | 2 | 2022 | 894 | 0.150 |
Why?
| | Dyneins | 1 | 2019 | 35 | 0.150 |
Why?
| | Altitude | 1 | 2023 | 473 | 0.150 |
Why?
| | Oligosaccharides | 3 | 2006 | 60 | 0.150 |
Why?
| | Adenosine Triphosphatases | 2 | 2022 | 161 | 0.150 |
Why?
| | Semen Analysis | 2 | 2020 | 14 | 0.150 |
Why?
| | Metabolic Networks and Pathways | 3 | 2022 | 187 | 0.140 |
Why?
| | Fertility | 1 | 2020 | 166 | 0.140 |
Why?
| | Infertility, Male | 2 | 2020 | 74 | 0.140 |
Why?
| | Aspartic Acid | 1 | 2018 | 87 | 0.140 |
Why?
| | Proteus penneri | 1 | 2008 | 1 | 0.140 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 5967 | 0.140 |
Why?
| | Basophils | 1 | 2018 | 52 | 0.140 |
Why?
| | Sodium Chloride | 2 | 2015 | 142 | 0.140 |
Why?
| | Anti-Allergic Agents | 1 | 2018 | 40 | 0.140 |
Why?
| | Spermatozoa | 2 | 2020 | 107 | 0.130 |
Why?
| | Omalizumab | 1 | 2018 | 43 | 0.130 |
Why?
| | Acetylation | 4 | 2019 | 249 | 0.130 |
Why?
| | Hypoxanthine | 1 | 2017 | 11 | 0.130 |
Why?
| | Mice, Knockout | 2 | 2023 | 3109 | 0.130 |
Why?
| | Myocytes, Cardiac | 1 | 2022 | 538 | 0.130 |
Why?
| | Urticaria | 1 | 2018 | 38 | 0.130 |
Why?
| | Protons | 2 | 2007 | 97 | 0.130 |
Why?
| | Mitochondria | 2 | 2022 | 984 | 0.130 |
Why?
| | Trastuzumab | 2 | 2022 | 117 | 0.130 |
Why?
| | Blood Transfusion | 3 | 2022 | 405 | 0.130 |
Why?
| | Fibrinolytic Agents | 2 | 2022 | 290 | 0.130 |
Why?
| | Basigin | 1 | 2017 | 24 | 0.130 |
Why?
| | Immune Sera | 2 | 2004 | 77 | 0.130 |
Why?
| | Chromatography, Affinity | 1 | 2017 | 80 | 0.120 |
Why?
| | Apoptosis | 3 | 2022 | 2397 | 0.120 |
Why?
| | Freeze Drying | 1 | 2017 | 81 | 0.120 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2018 | 562 | 0.120 |
Why?
| | Microtubules | 1 | 2019 | 287 | 0.120 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 7 | 0.120 |
Why?
| | DNA | 2 | 2022 | 1447 | 0.120 |
Why?
| | Preoperative Period | 1 | 2017 | 149 | 0.120 |
Why?
| | Purines | 1 | 2017 | 187 | 0.120 |
Why?
| | Healthy Volunteers | 1 | 2017 | 215 | 0.120 |
Why?
| | Saline Solution, Hypertonic | 1 | 2016 | 43 | 0.120 |
Why?
| | Mammals | 3 | 2022 | 296 | 0.120 |
Why?
| | Isotope Labeling | 1 | 2017 | 83 | 0.120 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 106 | 0.120 |
Why?
| | Pancreas | 1 | 2018 | 341 | 0.120 |
Why?
| | Gene Expression Profiling | 3 | 2021 | 1766 | 0.120 |
Why?
| | Fibroblasts | 1 | 2021 | 1019 | 0.120 |
Why?
| | Epithelial Cells | 2 | 2016 | 1106 | 0.120 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2016 | 25 | 0.120 |
Why?
| | Receptor, PAR-2 | 1 | 2015 | 6 | 0.110 |
Why?
| | Rats, Sprague-Dawley | 3 | 2018 | 2521 | 0.110 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 153 | 0.110 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2015 | 26 | 0.110 |
Why?
| | Bison | 1 | 2015 | 6 | 0.110 |
Why?
| | Plasminogen | 1 | 2015 | 27 | 0.110 |
Why?
| | Workflow | 1 | 2017 | 182 | 0.110 |
Why?
| | Chemical Fractionation | 1 | 2015 | 29 | 0.110 |
Why?
| | Gelsolin | 1 | 2014 | 10 | 0.110 |
Why?
| | Hafnia alvei | 1 | 2004 | 1 | 0.110 |
Why?
| | Kallikreins | 1 | 2014 | 25 | 0.110 |
Why?
| | Glycosylation | 1 | 2015 | 161 | 0.110 |
Why?
| | Microcirculation | 1 | 2015 | 141 | 0.110 |
Why?
| | Glutamine | 1 | 2015 | 108 | 0.110 |
Why?
| | Serine Proteases | 1 | 2014 | 26 | 0.110 |
Why?
| | Myocardial Infarction | 1 | 2022 | 1209 | 0.110 |
Why?
| | Rats, Inbred F344 | 1 | 2015 | 268 | 0.110 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 3 | 2007 | 179 | 0.100 |
Why?
| | Aquaporin 4 | 1 | 2015 | 98 | 0.100 |
Why?
| | Blood Component Transfusion | 1 | 2015 | 104 | 0.100 |
Why?
| | Complex Mixtures | 1 | 2014 | 12 | 0.100 |
Why?
| | Bacterial Proteins | 4 | 2022 | 981 | 0.100 |
Why?
| | Skull | 1 | 2015 | 161 | 0.100 |
Why?
| | Peptide Hydrolases | 1 | 2014 | 105 | 0.100 |
Why?
| | Organ Size | 1 | 2015 | 461 | 0.100 |
Why?
| | Blotting, Western | 2 | 2011 | 1161 | 0.100 |
Why?
| | Glycoconjugates | 1 | 2003 | 7 | 0.100 |
Why?
| | Tetanus Toxoid | 1 | 2003 | 34 | 0.100 |
Why?
| | Homeostasis | 2 | 2022 | 639 | 0.100 |
Why?
| | Thromboplastin | 1 | 2023 | 64 | 0.100 |
Why?
| | Neural Stem Cells | 1 | 2015 | 167 | 0.100 |
Why?
| | Muscle, Skeletal | 2 | 2023 | 1788 | 0.100 |
Why?
| | Stem Cell Niche | 1 | 2013 | 57 | 0.100 |
Why?
| | Cluster Analysis | 1 | 2014 | 516 | 0.100 |
Why?
| | Neuromyelitis Optica | 1 | 2015 | 137 | 0.100 |
Why?
| | High-Throughput Screening Assays | 1 | 2015 | 176 | 0.100 |
Why?
| | Survival of Motor Neuron 2 Protein | 1 | 2012 | 5 | 0.100 |
Why?
| | Prognosis | 2 | 2022 | 4312 | 0.090 |
Why?
| | Cumulus Cells | 1 | 2012 | 6 | 0.090 |
Why?
| | Pyruvates | 1 | 2022 | 24 | 0.090 |
Why?
| | Inosine | 1 | 2022 | 14 | 0.090 |
Why?
| | Spinal Muscular Atrophies of Childhood | 1 | 2012 | 18 | 0.090 |
Why?
| | Ubiquitin-Specific Peptidase 7 | 1 | 2022 | 4 | 0.090 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2022 | 25 | 0.090 |
Why?
| | Leukocyte Count | 1 | 2013 | 315 | 0.090 |
Why?
| | Central Nervous System | 1 | 2015 | 279 | 0.090 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2017 | 187 | 0.090 |
Why?
| | Endotoxins | 1 | 2003 | 218 | 0.090 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 532 | 0.090 |
Why?
| | Pilot Projects | 1 | 2018 | 1886 | 0.090 |
Why?
| | Lymphoid Tissue | 1 | 2022 | 78 | 0.090 |
Why?
| | Maternal Age | 1 | 2012 | 126 | 0.090 |
Why?
| | Solute Carrier Family 22 Member 5 | 1 | 2022 | 7 | 0.090 |
Why?
| | Acute Lung Injury | 2 | 2015 | 301 | 0.090 |
Why?
| | Catalase | 1 | 2022 | 133 | 0.090 |
Why?
| | Ubiquitin | 1 | 2022 | 83 | 0.090 |
Why?
| | Quality Control | 1 | 2022 | 164 | 0.090 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 334 | 0.090 |
Why?
| | Phosphates | 1 | 2022 | 177 | 0.090 |
Why?
| | Oxygen Consumption | 1 | 2014 | 717 | 0.090 |
Why?
| | beta 2-Microglobulin | 1 | 2011 | 47 | 0.090 |
Why?
| | Leukocytes | 1 | 2013 | 294 | 0.090 |
Why?
| | Datasets as Topic | 2 | 2022 | 119 | 0.090 |
Why?
| | Galactosyltransferases | 1 | 2011 | 12 | 0.080 |
Why?
| | Sialyltransferases | 1 | 2011 | 13 | 0.080 |
Why?
| | Transfusion Reaction | 1 | 2011 | 61 | 0.080 |
Why?
| | Transglutaminases | 1 | 2022 | 159 | 0.080 |
Why?
| | Young Adult | 4 | 2021 | 14122 | 0.080 |
Why?
| | RNA-Binding Proteins | 1 | 2015 | 461 | 0.080 |
Why?
| | Histones | 2 | 2022 | 663 | 0.080 |
Why?
| | STAT3 Transcription Factor | 1 | 2022 | 205 | 0.080 |
Why?
| | HeLa Cells | 1 | 2012 | 632 | 0.080 |
Why?
| | Linoleic Acid | 1 | 2021 | 44 | 0.080 |
Why?
| | Mice, SCID | 1 | 2021 | 368 | 0.080 |
Why?
| | Adenosine | 1 | 2022 | 255 | 0.080 |
Why?
| | Cell Self Renewal | 1 | 2021 | 52 | 0.080 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2006 | 141 | 0.080 |
Why?
| | Cardiac Surgical Procedures | 1 | 2017 | 609 | 0.080 |
Why?
| | Immunoglobulin G | 1 | 2015 | 886 | 0.080 |
Why?
| | Disease Models, Animal | 4 | 2023 | 4539 | 0.080 |
Why?
| | Rabbits | 3 | 2014 | 651 | 0.080 |
Why?
| | Substrate Specificity | 1 | 2011 | 392 | 0.080 |
Why?
| | HEK293 Cells | 1 | 2012 | 743 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 906 | 0.080 |
Why?
| | Astrocytes | 1 | 2022 | 228 | 0.080 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 610 | 0.080 |
Why?
| | Lipids | 2 | 2023 | 706 | 0.080 |
Why?
| | Phenylthiohydantoin | 1 | 2019 | 44 | 0.070 |
Why?
| | Bordetella pertussis | 1 | 2009 | 4 | 0.070 |
Why?
| | Glucosamine | 1 | 2009 | 14 | 0.070 |
Why?
| | B-Lymphocytes | 1 | 2015 | 875 | 0.070 |
Why?
| | Phenotype | 1 | 2017 | 3147 | 0.070 |
Why?
| | Models, Molecular | 2 | 2020 | 1610 | 0.070 |
Why?
| | Risk Factors | 1 | 2023 | 10796 | 0.070 |
Why?
| | Peptides | 1 | 2015 | 989 | 0.070 |
Why?
| | DNA Damage | 1 | 2022 | 430 | 0.070 |
Why?
| | Histone Acetyltransferases | 1 | 2019 | 57 | 0.070 |
Why?
| | Miller Fisher Syndrome | 1 | 2008 | 2 | 0.070 |
Why?
| | Mitochondrial Proteins | 1 | 2011 | 262 | 0.070 |
Why?
| | Escherichia coli | 1 | 2003 | 854 | 0.070 |
Why?
| | Guillain-Barre Syndrome | 1 | 2008 | 23 | 0.070 |
Why?
| | Benzamides | 1 | 2019 | 224 | 0.070 |
Why?
| | Multigene Family | 1 | 2009 | 210 | 0.070 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 926 | 0.070 |
Why?
| | Nitriles | 1 | 2019 | 205 | 0.070 |
Why?
| | Membrane Glycoproteins | 1 | 2011 | 496 | 0.070 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5414 | 0.070 |
Why?
| | N-Acetylneuraminic Acid | 1 | 2007 | 16 | 0.070 |
Why?
| | DNA-Binding Proteins | 1 | 2015 | 1484 | 0.070 |
Why?
| | Pregnancy | 3 | 2023 | 7122 | 0.060 |
Why?
| | Cell Adhesion | 2 | 2020 | 452 | 0.060 |
Why?
| | Unfolded Protein Response | 1 | 2017 | 58 | 0.060 |
Why?
| | Membrane Proteins | 2 | 2020 | 1159 | 0.060 |
Why?
| | Molecular Weight | 1 | 2017 | 312 | 0.060 |
Why?
| | Multiple Myeloma | 1 | 2021 | 306 | 0.060 |
Why?
| | Hydrolysis | 1 | 2017 | 198 | 0.060 |
Why?
| | Carrier Proteins | 1 | 2011 | 733 | 0.060 |
Why?
| | Protein Binding | 2 | 2017 | 2243 | 0.060 |
Why?
| | Protein Aggregates | 1 | 2017 | 84 | 0.060 |
Why?
| | Butyrophilins | 1 | 2016 | 5 | 0.060 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2017 | 146 | 0.060 |
Why?
| | Lipid Droplets | 1 | 2016 | 19 | 0.060 |
Why?
| | Critical Illness | 1 | 2013 | 888 | 0.060 |
Why?
| | Glycine | 1 | 2007 | 186 | 0.060 |
Why?
| | Flow Cytometry | 3 | 2015 | 1154 | 0.060 |
Why?
| | Cross Reactions | 2 | 2008 | 130 | 0.060 |
Why?
| | Obesity | 1 | 2020 | 3070 | 0.060 |
Why?
| | Mammary Glands, Human | 1 | 2016 | 68 | 0.060 |
Why?
| | Cytoplasm | 1 | 2016 | 257 | 0.060 |
Why?
| | Reproducibility of Results | 1 | 2014 | 3414 | 0.060 |
Why?
| | Prospective Studies | 1 | 2017 | 7994 | 0.060 |
Why?
| | Monocytes | 2 | 2023 | 536 | 0.050 |
Why?
| | Lactation | 1 | 2016 | 192 | 0.050 |
Why?
| | Methylation | 2 | 2018 | 241 | 0.050 |
Why?
| | Models, Chemical | 2 | 2006 | 264 | 0.050 |
Why?
| | Aged | 4 | 2021 | 25955 | 0.050 |
Why?
| | Chromosome Segregation | 2 | 2015 | 48 | 0.050 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2016 | 200 | 0.050 |
Why?
| | 2,3-Diphosphoglycerate | 1 | 2023 | 32 | 0.050 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 17 | 0.050 |
Why?
| | Kynurenine | 1 | 2024 | 103 | 0.050 |
Why?
| | Pelvic Floor | 1 | 2023 | 32 | 0.050 |
Why?
| | Molecular Structure | 2 | 2009 | 495 | 0.050 |
Why?
| | Angiopoietins | 1 | 2022 | 12 | 0.050 |
Why?
| | Parturition | 1 | 2023 | 68 | 0.050 |
Why?
| | Pancreatic Elastase | 1 | 2022 | 53 | 0.050 |
Why?
| | Thymidine | 1 | 2022 | 60 | 0.050 |
Why?
| | Brain | 1 | 2015 | 2934 | 0.050 |
Why?
| | Cohort Studies | 1 | 2023 | 5957 | 0.050 |
Why?
| | Serine Proteinase Inhibitors | 1 | 2022 | 48 | 0.050 |
Why?
| | Random Allocation | 1 | 2023 | 366 | 0.050 |
Why?
| | Erythropoiesis | 1 | 2022 | 57 | 0.040 |
Why?
| | alpha-Globins | 1 | 2022 | 9 | 0.040 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 2022 | 59 | 0.040 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 82 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2022 | 248 | 0.040 |
Why?
| | Pentose Phosphate Pathway | 1 | 2021 | 55 | 0.040 |
Why?
| | Embryo, Mammalian | 1 | 2022 | 232 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2022 | 269 | 0.040 |
Why?
| | Mutation | 1 | 2022 | 4081 | 0.040 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 27 | 0.040 |
Why?
| | Membrane Microdomains | 1 | 2021 | 34 | 0.040 |
Why?
| | Least-Squares Analysis | 1 | 2021 | 74 | 0.040 |
Why?
| | Access to Information | 1 | 2021 | 47 | 0.040 |
Why?
| | Polymorphism, Genetic | 1 | 2023 | 613 | 0.040 |
Why?
| | Fibrosis | 1 | 2023 | 547 | 0.040 |
Why?
| | Bacteriophage lambda | 1 | 2021 | 90 | 0.040 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 171 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 572 | 0.040 |
Why?
| | Chromatin | 2 | 2015 | 554 | 0.040 |
Why?
| | Sulfhydryl Compounds | 1 | 2022 | 188 | 0.040 |
Why?
| | Data Mining | 1 | 2021 | 115 | 0.040 |
Why?
| | Phosphorylation | 2 | 2015 | 1704 | 0.040 |
Why?
| | Sperm Count | 1 | 2020 | 21 | 0.040 |
Why?
| | Fatty Acids | 1 | 2023 | 454 | 0.040 |
Why?
| | Heterozygote | 1 | 2021 | 313 | 0.040 |
Why?
| | Sperm Motility | 1 | 2020 | 35 | 0.040 |
Why?
| | Hematopoiesis | 1 | 2021 | 193 | 0.040 |
Why?
| | Adolescent | 2 | 2020 | 22409 | 0.040 |
Why?
| | Cell Differentiation | 2 | 2020 | 2037 | 0.040 |
Why?
| | Specimen Handling | 1 | 2021 | 187 | 0.040 |
Why?
| | Tissue Survival | 1 | 2018 | 16 | 0.040 |
Why?
| | Neoplasm Invasiveness | 1 | 2020 | 503 | 0.040 |
Why?
| | Pepsin A | 1 | 2018 | 18 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 1 | 2022 | 477 | 0.040 |
Why?
| | Blood Buffy Coat | 1 | 2018 | 5 | 0.040 |
Why?
| | NF-kappa B | 1 | 2022 | 657 | 0.040 |
Why?
| | Cell Communication | 1 | 2020 | 325 | 0.040 |
Why?
| | Sulfates | 1 | 2018 | 51 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 2018 | 75 | 0.030 |
Why?
| | Fluorescence | 1 | 2018 | 153 | 0.030 |
Why?
| | Filtration | 1 | 2018 | 70 | 0.030 |
Why?
| | Solutions | 1 | 2018 | 166 | 0.030 |
Why?
| | Bacteriological Techniques | 1 | 2018 | 68 | 0.030 |
Why?
| | Deamination | 1 | 2017 | 6 | 0.030 |
Why?
| | Complement Activation | 1 | 2021 | 409 | 0.030 |
Why?
| | DNA Methylation | 1 | 2022 | 664 | 0.030 |
Why?
| | Inpatients | 1 | 2022 | 547 | 0.030 |
Why?
| | Calcium | 1 | 2023 | 1182 | 0.030 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 21 | 0.030 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2019 | 580 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1374 | 0.030 |
Why?
| | Bronchioles | 1 | 2016 | 29 | 0.030 |
Why?
| | Electron Spin Resonance Spectroscopy | 1 | 2006 | 96 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 98 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 621 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2020 | 643 | 0.030 |
Why?
| | Comorbidity | 1 | 2021 | 1652 | 0.030 |
Why?
| | Amides | 1 | 2006 | 99 | 0.030 |
Why?
| | Chromatids | 1 | 2015 | 10 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2847 | 0.030 |
Why?
| | Tumor Burden | 1 | 2017 | 324 | 0.030 |
Why?
| | HMGA2 Protein | 1 | 2015 | 10 | 0.030 |
Why?
| | Bromodeoxyuridine | 1 | 2015 | 77 | 0.030 |
Why?
| | Isotonic Solutions | 1 | 2015 | 42 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2015 | 129 | 0.030 |
Why?
| | Mice, Nude | 1 | 2017 | 677 | 0.030 |
Why?
| | Chromosomes | 1 | 2015 | 108 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 473 | 0.030 |
Why?
| | Electroporation | 1 | 2015 | 43 | 0.030 |
Why?
| | Carbohydrate Conformation | 1 | 2004 | 15 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2015 | 147 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2017 | 243 | 0.030 |
Why?
| | Immunoglobulin Light Chains | 1 | 2015 | 51 | 0.030 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2015 | 85 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2018 | 578 | 0.030 |
Why?
| | Serologic Tests | 1 | 2004 | 53 | 0.030 |
Why?
| | Seminal Plasma Proteins | 1 | 2014 | 11 | 0.030 |
Why?
| | Transfection | 1 | 2017 | 924 | 0.030 |
Why?
| | Tranexamic Acid | 1 | 2015 | 55 | 0.030 |
Why?
| | Chromosomal Instability | 1 | 2014 | 21 | 0.030 |
Why?
| | Embryo Implantation | 1 | 2014 | 30 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 339 | 0.030 |
Why?
| | Fetal Stem Cells | 1 | 2013 | 8 | 0.030 |
Why?
| | Fertilization in Vitro | 1 | 2014 | 92 | 0.020 |
Why?
| | Embryonic Development | 1 | 2014 | 123 | 0.020 |
Why?
| | Species Specificity | 1 | 2004 | 573 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2015 | 1046 | 0.020 |
Why?
| | Models, Biological | 1 | 2021 | 1811 | 0.020 |
Why?
| | DNA Repair | 1 | 2015 | 256 | 0.020 |
Why?
| | Microscopy, Atomic Force | 1 | 2013 | 132 | 0.020 |
Why?
| | Cell Count | 1 | 2013 | 320 | 0.020 |
Why?
| | Oocyte Donation | 1 | 2012 | 4 | 0.020 |
Why?
| | Immunoblotting | 1 | 2003 | 293 | 0.020 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 364 | 0.020 |
Why?
| | Amino Acids | 1 | 2017 | 521 | 0.020 |
Why?
| | Synovial Membrane | 1 | 2013 | 124 | 0.020 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2004 | 346 | 0.020 |
Why?
| | Cell Movement | 1 | 2017 | 959 | 0.020 |
Why?
| | Silver Staining | 1 | 2002 | 16 | 0.020 |
Why?
| | Disaccharides | 1 | 2002 | 21 | 0.020 |
Why?
| | Chronic Disease | 1 | 2018 | 1810 | 0.020 |
Why?
| | Wounds, Nonpenetrating | 1 | 2015 | 321 | 0.020 |
Why?
| | Wnt Signaling Pathway | 1 | 2013 | 210 | 0.020 |
Why?
| | Body Mass Index | 1 | 2020 | 2419 | 0.020 |
Why?
| | Cell Cycle | 1 | 2014 | 595 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2013 | 372 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2017 | 1437 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2446 | 0.020 |
Why?
| | Hemodynamics | 1 | 2015 | 1113 | 0.020 |
Why?
| | Antibodies | 1 | 2002 | 396 | 0.020 |
Why?
| | Gene Order | 1 | 2009 | 28 | 0.020 |
Why?
| | Glycosyltransferases | 1 | 2009 | 16 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2009 | 68 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 1847 | 0.020 |
Why?
| | Databases, Factual | 1 | 2015 | 1494 | 0.020 |
Why?
| | Chromatography, Thin Layer | 1 | 2008 | 25 | 0.020 |
Why?
| | Endopeptidase K | 1 | 2008 | 18 | 0.020 |
Why?
| | Genes, Bacterial | 1 | 2009 | 170 | 0.020 |
Why?
| | Gene Knockout Techniques | 1 | 2009 | 117 | 0.020 |
Why?
| | Deoxyribonucleases | 1 | 2008 | 24 | 0.020 |
Why?
| | Cytokines | 1 | 2016 | 2045 | 0.020 |
Why?
| | Microwaves | 1 | 2008 | 29 | 0.020 |
Why?
| | Acylation | 1 | 2007 | 30 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 2008 | 347 | 0.020 |
Why?
| | Child | 1 | 2023 | 22600 | 0.010 |
Why?
|
|
Headrick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|